| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for AstraZeneca plc > News item |
AstraZeneca to issue fixed-rate notes due 2026, 2030 and 2050
Chicago, Aug. 3 – AstraZeneca plc intends to offer notes in three tranches, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will be sold in three fixed-rate tranches due 2026, 2030 and 2050.
The bonds will feature a make-whole call and a par call.
Joint bookrunners for the offering are BofA Securities Inc., HSBC Securities (USA) Inc. and Mizuho Securities USA Inc.
Proceeds will be used for general corporate purposes which may include refinancing debt.
The biopharmaceutical company is based in Cambridge, England.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.